Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hMSC for Agitation/Aggression in Alzheimer's Disease
NCT06781333Phase 2Recruiting
- Start
- Apr 2025
- Primary completion
- Dec 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human mesenchymal stem cells in Dementia. Started Apr 2025; status: recruiting.
02
Drugs
human mesenchymal stem cells
03
Conditions
Dementia
Beyond the preview
Go deeper on NCT06781333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06781333.